美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=RELA"
符合检索条件的记录共 22 条
共 2 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
RELA 012155 001 NDA CARISOPRODOL TABLET;ORAL 350MG No No -- Approved Prior to Jan 1, 1982 SCHERING Discontinued
VERELAN 019614 001 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Yes No 1990/05/29 1990/05/29 SOCIETAL CDMO Prescription
VERELAN 019614 002 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 240MG Yes No 1990/05/29 1990/05/29 SOCIETAL CDMO Prescription
VERELAN 019614 003 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 180MG Yes No 1990/05/29 1992/01/09 SOCIETAL CDMO Prescription
VERELAN 019614 004 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 360MG Yes Yes 1990/05/29 1996/05/10 SOCIETAL CDMO Prescription
RELAFEN 019583 001 NDA NABUMETONE TABLET;ORAL 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 1991/12/24 1991/12/24 SMITHKLINE BEECHAM Discontinued
RELAFEN 019583 002 NDA NABUMETONE TABLET;ORAL 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Yes No 1991/12/24 1991/12/24 SMITHKLINE BEECHAM Discontinued
NAPRELAN 020353 001 NDA NAPROXEN SODIUM TABLET, EXTENDED RELEASE;ORAL EQ 375MG BASE Yes No 1996/01/05 1996/01/05 TWI PHARMS Prescription
NAPRELAN 020353 002 NDA NAPROXEN SODIUM TABLET, EXTENDED RELEASE;ORAL EQ 500MG BASE Yes No 1996/01/05 1996/01/05 TWI PHARMS Prescription
NAPRELAN 020353 003 NDA NAPROXEN SODIUM TABLET, EXTENDED RELEASE;ORAL EQ 750MG BASE Yes Yes 1996/01/05 1996/01/05 TWI PHARMS Prescription
PRELAY 020719 001 NDA TROGLITAZONE TABLET;ORAL 200MG No No 1997/01/29 1997/01/29 SANKYO Discontinued
PRELAY 020719 002 NDA TROGLITAZONE TABLET;ORAL 400MG No No 1997/01/29 1997/01/29 SANKYO Discontinued
PRELAY 020719 003 NDA TROGLITAZONE TABLET;ORAL 300MG No No 1997/01/29 1997/08/04 SANKYO Discontinued
VERELAN PM 020943 001 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 100MG Yes No 1998/11/25 1998/11/25 SOCIETAL CDMO Prescription
VERELAN PM 020943 002 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 200MG Yes No 1998/11/25 1998/11/25 SOCIETAL CDMO Prescription
VERELAN PM 020943 003 NDA VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 300MG Yes Yes 1998/11/25 1998/11/25 SOCIETAL CDMO Prescription
VANTRELA ER 207975 001 NDA HYDROCODONE BITARTRATE TABLET, EXTENDED RELEASE;ORAL 15MG Yes No 2017/01/17 2017/01/17 TEVA BRANDED PHARM Discontinued
VANTRELA ER 207975 002 NDA HYDROCODONE BITARTRATE TABLET, EXTENDED RELEASE;ORAL 30MG Yes No 2017/01/17 2017/01/17 TEVA BRANDED PHARM Discontinued
VANTRELA ER 207975 003 NDA HYDROCODONE BITARTRATE TABLET, EXTENDED RELEASE;ORAL 45MG Yes No 2017/01/17 2017/01/17 TEVA BRANDED PHARM Discontinued
VANTRELA ER 207975 004 NDA HYDROCODONE BITARTRATE TABLET, EXTENDED RELEASE;ORAL 60MG Yes No 2017/01/17 2017/01/17 TEVA BRANDED PHARM Discontinued
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database